Scynexis SCYX
NASDAQ SCYX
$5.24 +0.09 (+1.65%)
At close: Aug 20, 2026 · 12:42 PM UTC

Scynexis (SCYX) Net Equity Issued and Repurchased (2016 - 2025)

Scynexis' (SCYX) quarterly Net Equity Issued and Repurchased came in at $1000.0 in Q4 2025, up 125.0% on a QoQ basis from -$4000.0 in Q3 2023.

Scynexis (SCYX) Net Equity Issued and Repurchased (2016 - 2025) Analysis & Trends

Scynexis (SCYX) has 9 years of Net Equity Issued and Repurchased data on file, last reported at $1000.0 in Q4 2025.

  • Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $1000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$3000.0 (changed N/A YoY) and the FY2025 annual result came in at $5000.0, changed N/A from the prior year.
  • Net Equity Issued and Repurchased rose to $1000.0 in Q4 2025, from -$4000.0 in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $30.5 million in Q4 2021 to a low of -$4000.0 in Q3 2023.
  • A 4-year average of $4.2 million and a median of $216968.5 in 2021 frame the typical range for Net Equity Issued and Repurchased.
  • Annual changes were most pronounced in 2021 — Net Equity Issued and Repurchased slumped 44.34% — and 2023, when it tumbled 104.0%.
  • Tracing SCYX's Net Equity Issued and Repurchased over 4 years: stood at $30.5 million in 2021, then sank by 99.67% to $100000.0 in 2022, then plunged by 104.0% to -$4000.0 in 2023, then soared by 125.0% to $1000.0 in 2025.
  • The last three Net Equity Issued and Repurchased figures came in at $1000.0 (Q4 2025), -$4000.0 (Q3 2023), and $4000.0 (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Haleon 43.96 Bn 43.00 Bn - -
2 Teva Pharmaceutical Industries 43.23 Bn 39.58 Bn 2.15 Bn -
3 Zoetis 31.76 Bn 30.08 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.68 Bn 22.88 Bn 5.10 Bn -
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn -
6 Viatris 18.69 Bn 17.81 Bn 1.46 Bn 700,000.00
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn 84.80 Mn
8 Elanco Animal Health 11.78 Bn 11.25 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn - -
10 Scynexis 61.90 Mn -52.80 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 1,000.00
Dec 31, 2025 1,000.00
Sep 30, 2023 -4,000.00
Sep 30, 2023 -4,000.00
Jun 30, 2023 4,000.00
Jun 30, 2023 4,000.00
Sep 30, 2022 100,000.00
Sep 30, 2022 100,000.00
Mar 31, 2022 2.16 Mn
Mar 31, 2022 2.16 Mn
Dec 31, 2021 30.53 Mn
Dec 31, 2021 30.53 Mn
Sep 30, 2021 333,937.00
Sep 30, 2021 333,937.00
Jun 30, 2021 800,000.00
Jun 30, 2021 800,000.00
Dec 31, 2020 85.85 Mn
Dec 31, 2020 85.85 Mn
Sep 30, 2020 600,000.00
Sep 30, 2020 600,000.00